Subjects: Ovarian Neoplasms -- drug therapy and Poly(ADP-ribose) Polymerase Inhibitors -- economics / Dates by Range: 2000 and later - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Ovarian Neoplasms -- drug therapy ✖ Subjects Poly(ADP-ribose) Polymerase Inhibitors -- economics ✖ Dates by Range 2000 and later ✖

1. Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
Subject(s):: Ovarian Neoplasms -- drug therapy
Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
Comparative Effectiveness Research
Poly(ADP-ribose) Polymerase Inhibitors -- adverse effects
Poly(ADP-ribose) Polymerase Inhibitors -- economics
Treatment Outcome
Humans
United States